UNSPSC 51152024: Dantrolene sodium

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 287M0347EV. European Medicines Agency schedules Dantrolene sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01553MIG. Dantrolene sodium generally arises in the molecular formula C14H9N4NAO5. The term DANTROLENE SODIUM is a United States Adopted Name designation. Most nations schedule dantrolene sodium under HS 29349990 and SITC 51579.

As of Q4 2014, DANTROLENE SODIUM remains the US FDA Preferred Term for this commodity. Dantrolene sodium bears US NLM identifiers UMLS ID C0010977 and NCI Concept Code C61698. SMILES: C1C(=O)N=C(N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-].[NA+].

UNSPSC 51152024 Dantrolene sodium (Commodity) covers pharmaceutical products and medications procured by state and local health agencies, though the recent solicitation activity under this code does not align with dantrolene specifically. Seminole County, Florida's IFB 60459723LAS sought naloxone and drug deactivation systems rather than dantrolene sodium, indicating a significant mismatch between the code's nominal scope and actual procurement. State and local governments use this code tier to procure specific pharmaceutical agents for public health and emergency response programs, but the available recent opportunities do not support a clear pattern of dantrolene sodium demand across jurisdictions.

Seminole County, a Florida county health agency, posted the naloxone and drug deactivation system IFB on June 30, 2026, with a response deadline of July 26, 2023 (a historical date now superseded), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The county required electronic bid submission through its e-Procurement Portal, full inclusion of shipping and delivery costs, drug-free workplace certification, and E-Verify compliance; the contract carried a two-year initial term with a one-year renewal option and potential FEMA funding. No additional state or local dantrolene sodium solicitations appear in the recent-opportunities record, limiting visibility into current market activity for this specific pharmaceutical under the code.